Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Refractive Surgery/Vision Correction > Iris-Claw Intraocular Lens Evaluated
  • General

Iris-Claw Intraocular Lens Evaluated

Ophthalmology 360
Article Image

The Artisan aphakia iris-claw intraocular lens (IOL) offered good visual outcomes and few complications, according to a retrospective case series involving 95 individuals. 

Participants received pre- (n=57) or retropupillary (n=38) implantation, mainly for IOL or lens luxation or subluxation, trauma, or aphakia. Investigators looked at corrected distance visual acuity, anatomical changes, endothelial cell count, cystoid macular edema presence, and operative and postoperative complications. Among the results: 

  • Corrected distance visual acuity improved significantly in both groups.
  • Endothelial cell counts were reduced in both groups. 
  • Cystoid macular edema incidence was 16% overall; the reduction was not significantly different between the 2 groups. 
  • Other postop complications were rare and no differences were found between groups.

Peralbaba R, Lamas-Francis D, Sarandeses-Diez T, Martinez-Perez L, Rodriguez-Ares T. Iris-claw intraocular lens for aphakia: Can location influence the final outcomes? J Cataract Refract Surg. 2018;44(7)818-826. doi: https://doi.org/10.1016/j.jcrs.2018.05.010.

Share

Related Content

  • General

Preserflo associated with fewer complications than Xen63 in glaucoma surgery

  • General

Glaucoma may signal complications in intraocular cancers, review suggests

  • General

XEN63 Gel Stent shows sustained glaucoma control over 3 years

  • General

Triple-layer decellularized amniotic membrane linked to low recurrence and minimal complications

  • General

Best of 2025: Imaging advances and therapeutic progress across ophthalmology

  • Cataract

It has never been a better time to be a cataract surgeon: trends and advancements in cataract and refractive surgery

34 Mins Watch

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon